Orbimed Advisors LLC Heron Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.32 - $3.86 $8.35 Million - $13.9 Million	-3,598,684 Reduced 35.59%	6,512,866 $22.8 Million
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $7.15 Million - $12.8 Million	4,182,959 Added 70.56%	10,111,550 $28 Million
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $2.77 Million - $9.33 Million	5,125,891 Added 638.58%	5,928,591 $10.1 Million
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $1.21 Million - $2.61 Million	802,700 New	802,700 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $2.99 Million - $6.03 Million	1,123,000 New	1,123,000 $4.74 Million
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $17.3 Million - $24.7 Million	-1,191,846 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.67 - $17.77 $7.26 Million - $9.44 Million	531,426 Added 80.47%	1,191,846 $17.7 Million
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $1.34 Million - $2.64 Million	123,000 Added 22.89%	660,420 $9.72 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $5.5 Million - $13.2 Million	537,420 New	537,420 $6.31 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $18.1 Million - $28 Million	-1,069,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $7.67 Million - $9.39 Million	-331,300 Reduced 23.66%	1,069,000 $26.1 Million
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $2.52 Million - $3.66 Million	-114,200 Reduced 7.54%	1,400,300 $36.3 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $5.98 Million - $8.15 Million	199,400 Added 15.16%	1,514,500 $47.9 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $4.63 Million - $7.36 Million	175,300 Added 15.38%	1,315,100 $51.1 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $9.03 Million - $14.1 Million	489,800 Added 75.35%	1,139,800 $31.5 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $9.52 Million - $11 Million	650,000	650,000 $10.5 Million

Others Institutions Holding HRTX

# of Institutions

181

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$31.8 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$10.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$9.91 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$8.31 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $141M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account